Protocols for perioperative management of direct oral anticoagulants in hospitals: opportunities for improvement

被引:2
|
作者
Mitrovic, Darko [1 ]
van Elp, Margriet [1 ]
Veeger, Nic [2 ,3 ]
Lameijer, Heleen [4 ]
Meijer, Karina [5 ]
van Roon, Eric [2 ,3 ]
机构
[1] Tjongerschans, Dept Hosp Pharm, Heerenveen, Netherlands
[2] Univ Groningen, Fac Pharm, Dept Pharmacotherapy Epidemiol & Econ, Groningen, Netherlands
[3] Med Ctr Leeuwarden, Dept Clin Pharm, Leeuwarden, Netherlands
[4] Med Ctr Leeuwarden, Dept Emergency Med, Leeuwarden, Netherlands
[5] Univ Groningen, Univ Med Ctr Groningen, Dept Haematol, Groningen, Netherlands
关键词
Perioperative management; DOAC; protocol; antidotes; PERIPROCEDURAL MANAGEMENT;
D O I
10.1080/03007995.2022.2141962
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To investigate and describe the protocolized perioperative management in patient using Direct oral anticoagulants (DOACs) in Dutch hospitals. Methods Between August and December 2020, a nationwide survey in 70 hospitals in the Netherlands was conducted. We asked hospital pharmacists to submit their protocols for perioperative management of DOAC (apixaban, dabigatran, edoxaban and rivaroxaban) users. The protocols were assessed for a number of parameters divided into categories: interruption and restart timetables DOACs for elective procedures, criteria for the start of an urgent procedure without antidotes, criteria for the use of antidotes and advised antidotes for urgent procedures. Results A total of 49 hospitals (70%) sent a protocol for perioperative management of DOACs. Two pairs of protocols were identical because hospitals cooperated closely, leaving 47 individual protocols for analysis. Thirty-five of these protocols contained a policy for both elective and urgent procedure; five protocols contained only a policy for elective and seven only for urgent procedures. In protocols for elective procedure, we found great variation in interruption and restart timetables intended for patients with renal impairment (Estimated Glomerular Filtration Ratio < 80 ml/min). In case of urgent procedures, there is variation in choice of antidote, criteria for administration of an antidote and antidote dosing. Conclusion This study provides an overview of the current state of the perioperative protocols in the Netherlands in patients treated with direct oral anticoagulants. Protocols are often not complete and show important and unwanted variation. We have found that national guidelines do not provide unambiguous advice on all points (urgent procedures) and are therefore often elaborated at a local level. The results of this research can help in improving and harmonizing the perioperative protocols on a national level.
引用
收藏
页码:13 / 18
页数:6
相关论文
共 50 条
  • [21] Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
    Burnett, Allison E.
    Mahan, Charles E.
    Vazquez, Sara R.
    Oertel, Lynn B.
    Garcia, David A.
    Ansell, Jack
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2016, 41 (01) : 206 - 232
  • [22] Perioperative management of new oral anticoagulants in patients undergoing elective surgery at a tertiary hospital
    Wamala, Henry
    Scott, Ian A.
    Caney, Xenia
    INTERNAL MEDICINE JOURNAL, 2017, 47 (12) : 1412 - 1421
  • [23] Direct-acting Oral Anticoagulants in Dermatologic Surgery
    Cabezas-Calderon, V
    Bassas Freixas, P.
    Garcia-Patos Briones, V
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (05): : 357 - 363
  • [24] Pharmacokinetics and pharmacodynamics of direct oral anticoagulants
    Hindley, B.
    Lip, G. Y. H.
    Mccloskey, A. P.
    Penson, P. E.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (12) : 911 - 923
  • [25] Anticoagulation-direct oral anticoagulants
    Kemkes-Matthes, B.
    INTERNIST, 2017, 58 (06): : 585 - 596
  • [26] Antidotes for reversal of direct oral anticoagulants
    Dobesh, Paul P.
    Bhatt, Snehal H.
    Trujillo, Toby C.
    Glaubius, Krissa
    PHARMACOLOGY & THERAPEUTICS, 2019, 204
  • [27] REVERSAL AGENTS FOR THE DIRECT ORAL ANTICOAGULANTS
    Ageno, W.
    BLOOD TRANSFUSION, 2016, 14 : S706 - S709
  • [28] Reversal Agents for the Direct Oral Anticoagulants
    Ansell, Jack E.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 30 (05) : 1085 - +
  • [29] Direct oral anticoagulants versus conventional anticoagulants for pulmonary embolism
    Long, Brit
    Gottlieb, Michael
    ACADEMIC EMERGENCY MEDICINE, 2023, 30 (10) : 1068 - 1070
  • [30] Clinical impact of perioperative management of oral anticoagulants in bleeding after colonic endoscopic mucosal resection
    Ono, Shoko
    Tanaka, Ikko
    Kinowaki, Sayoko
    Inoue, Masaki
    Matsuda, Kana
    Ishikawa, Marin
    Tsuda, Momoko
    Yamamoto, Keiko
    Shimizu, Yuichi
    Sakamoto, Naoya
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 242 - 242